Friday September 22, 2017 13:23

BIONET-ASIA Press Releases

BioNet-Asia Organized International Pertussis Symposium Celebrating its 15th Anniversary in Bangkok IT—21 Apr 17

BioNet-Asia Co. Ltd organized the first International Symposium on Advances in Pertussis Immunisation in Bangkok, Thailand. The Symposium was attended by more than 300 international and Thai experts on pertussis vaccination as well as public health

BioNet Received Thai FDA Approval of the Worlds Only Available Recombinant Monovalent Acellular Pertussis (aP) Vaccine Heathcare—23 Dec 16

BioNet's vaccine is the first recombinant monovalent Pertussis vaccine in the world to receive a MAA for booster indication in adolescents and adults BioNet-Asia announced today that its first recombinant acellular Pertussis booster vaccine containing a

BioNet-Asia Announces the Formation of its Scientific Advisory Board Heathcare—22 Mar 16

BioNet Announces the Appointment of Dr. Stanley Plotkin as Chairman of the Scientific Advisory Board BioNet-Asia, an innovative clinical stage vaccine company, announced the formation of BioNet Scientific Advisory Board (SAB), under the chairmanship of

Vaccine Global Access a priority as DCVMN Annual Conference concludes Heathcare—08 Oct 15

The 16th AGM and Annual Conference of the Developing Countries Vaccine Manufacturers Network (DCVMN) came to a close today after four days of productive interactions between more than 300 stakeholders. Co-hosted by the Queen Saovabha Memorial Institute

BioNet strengthens advisory board with appointment of vaccine veteran Jacques-Fran?ois Heathcare—19 Dec 14

BioNet-Asia appoints Jacques-François Martin to its advisory board as it moves its Recombinant Pertussis vaccine into Phase II/III. BioNet-Asia (BioNet), a vaccine company focused on innovative vaccine discovery and supply, announced that vaccine

BioNet Appoints New COO and Accelerates the Development of New Recombinant Pertussis General—28 Oct 14

BANGKOK--(BUSINESS WIRE)--Oct. 28, 2014 - BioNet-Asia appoints Georges Thiry as COO and moves to next development phase of its Recombinant Pertussis vaccine after getting promising clinical results BioNet-Asia, a vaccine company focused on vaccine

BioNet Appoints New COO and Accelerates the Development of New Recombinant Pertussis Heathcare—28 Oct 14

BioNet-Asia appoints Georges Thiry as COO and moves to next development phase of its Recombinant Pertussis vaccine after getting promising clinical results BioNet-Asia, a vaccine company focused on vaccine discovery and supply, announced that Georges

BioNet Provides Update on Recombinant Acellular Pertussis Vaccine at BioJapan Lifestyle—17 Oct 14

BioNet Recombinant Pertussis vaccine shows safety and immunogenicity in Phase I/II Clinical Study BioNet-Asia's CEO, Dr Pham Hong Thai provided today an update on the company lead vaccine program in his presentation at BioJapan 2014. Dr Pham said that

BioNet Provides Update on Recombinant Acellular Pertussis Vaccine at BioJapan General—16 Oct 14

BioNet Recombinant Pertussis vaccine shows safety and immunogenicity in Phase I/II Clinical Study BioNet-Asia's CEO, Dr Pham Hong Thai provided today an update on the company lead vaccine program in his presentation at BioJapan 2014. Dr Pham said that

Photo Release: Asian manufacturers to bring new Rabies vaccine Heathcare—28 Sep 14

BioNet-Asia Co., Ltd. led by Mr. Vitoon Vonghangool (2nd from right), Managing Director, recently organized a MOU Signing Ceremony on the Collaboration in Manufacturing Rabies Vaccine in Thailand with Queen Saovabha Memorial Institute (QSMI) of the Thai

Asian manufacturers to bring new Rabies vaccine Heathcare—18 Sep 14

Queen Saovabha Memorial Institute, BioNet-Asia and Liaoning Cheng Da Biotechnology jointly announce a collaboration to manufacture the next generation Rabies vaccine in Thailand. The rabies vaccine manufacturing collaboration was signed today between

BioNet re-opens Vaccine Pilot Plant and expands manufacturing capabilities General—25 Jan 13

BioNet re-opens Vaccine Pilot Plant and expands manufacturing capabilities to meet ASEAN needs Plans to invest Baht 8 billion during next 10 years Ayutthaya, Thailand - BioNet-Asia Co., Ltd., a biotech company in Thailand focusing on the development,

BioNet to enter Hepatitis B vaccine production Heathcare—28 May 12

Could become the only company in the world to produce both recombinant acellular pertussis and recombinant Hepatitis B vaccines BioNet-Asia Co., Ltd., the only privately-owned biotech company in Thailand focusing on the development, manufacturing and

Photo Release: Symposium on the result of safety and immunogenicity of Heathcare—23 May 12

Mr. Vitoon Vonghangool (2nd left), Managing Director of BioNet-Asia Co., Ltd. recently presided over the symposium on “SPEEDA ID regimen study result by The Queen Saovabha Memorial Institute and Safety and Immunogenicity result of JEVAC Clinical

Photo release: First ever Tetanus-Diphtheria vaccine bulk filling collaboration brings affordable Heathcare—02 May 12

H.E. Lutfi Rauf (center), Indonesian Ambassador to Thailand, recently presided over the Signing Ceremony of the Tetanus-Diphtheria (Td) vaccine filling collaboration between Queen Saovabha Memorial Institute (QSMI) of the Thai Red Cross Society,

Photo Release: KMUTT and Biotec join hands with BioNet-Asia on quality control for vaccine Heathcare—03 Apr 12

KMUTT by Assoc. Prof. Dr. Sakarindr Bhumiratana, President of KMUTT and Biotec, NSTDA (National Science and Technology Development Agency) by Assoc. Prof. Dr. Suvit Tia, Deputy Executive Director of Biotec have recently signed a MOU with BioNet-Asia Co.,

Thailand to accelerate vaccine development and production capability Heathcare—25 Jan 11

In celebrating its 10th Anniversary, BioNet-Asia Co., Ltd., the only privately-owned vaccine research and development company in Thailand, incorporation with the National Vaccine Institute organized a symposium today on ‘Building Vaccine

First R&D Centre to develop recombinant acellular pertussis vaccine in Thailand Heathcare—15 Jan 09

BioNet-Asia Co., Ltd. today opened the first Thai private R&D Center and vaccine pilot plant dedicated to the development of bacterial vaccines in Thailand, located in the Hi-Tech Industrial Estate of Ayudhaya. The opening ceremony was presided over by

BioNet-Asia’s Research & Development Center The First GMP Pilot Vaccine Production Facility in General—07 Nov 07

BioNet-Asia’s Research & Development Center The First GMP Pilot Vaccine Production Facility in Thailand Development of new Acellular Pertussis Vaccine BioNet-Asia Co., Ltd. announces the first state-of-the-art GMP vaccine facility for develop